Title

Therapeutic Effects of a Novel Fusion of ALT-803, an IL-15 Superagonist, with 4 Single-Chains of Anti-CD20 Antibody (2B8T2M) in Combination with Expanded Natural Killer Cells Against Rituximab Sensitive and Resistant Burkitt Lymphoma (BL)

Document Type

Abstract

Publication Date

3-2018

Department

Pediatrics

Second Department

Health Behavior and Community Health

This document is currently not available here.

COinS